EXOZ
eXoZymes, Inc.NASDAQHealthcare$8.74+14.99%ClosedMarket Cap: $73.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
24.79
P/S
0.00
EV/EBITDA
0.00
DCF Value
$0.14
FCF Yield
-7.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-147.2%
ROA
-153.4%
ROIC
-203.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-2.7M | $-2.7M | $-0.32 | — |
| FY 2025 | $0.00 | NaN% | $-9.7M | $-9.2M | $-1.09 | — |
| Q3 2025 | $0.00 | -Infinity% | $-2.5M | $-2.3M | $-0.27 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.5M | $-2.4M | $-0.28 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.0M | $-1.9M | $-0.22 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.0M | $-1.8M | $-0.45 | — |
| FY 2024 | $0.00 | -Infinity% | $-5.9M | $-5.9M | $-0.72 | — |
| Q3 2024 | $0.00 | -Infinity% | $-1.6M | $-1.7M | $-0.20 | — |
| Q2 2024 | $0.00 | -Infinity% | $-1.3M | $-1.4M | $-0.17 | — |
| Q1 2024 | $0.00 | NaN% | $-1.0M | $-1.0M | $-0.12 | — |
| Q4 2023 | $0.00 | NaN% | $-985.0K | $-1.1M | $-0.14 | — |
| FY 2023 | $0.00 | NaN% | $-1.8M | $-2.0M | $-0.25 | — |